What is TuHURA Biosciences, Inc.'s repayments of assumed debt?

TuHURA Biosciences, Inc. (HURA) reported repayments of assumed debt of $108.5K in Q4 2025.

What does repayments of assumed debt mean?

This measures the cash outflows used to satisfy debt obligations that were inherited through a business acquisition or merger. It reflects the company's commitment to deleveraging and managing the capital structure post-transaction.

TuHURA Biosciences, Inc. HURA Repayments Of Assumed Debt

Repayments Of Assumed Debt at other companies

TuHURA Biosciences, Inc.HURA

$108.5K—

Pangaea Logistics SolutionsPANL

$4.22M+2.2%

Fox Factory Holding Corp.FOXF

$11.72M+93.0%

RadNetRDNT

$5.25M+5.0%

MTD

Matador ResourcesMTDR

$105M+5.0%

Cineverse Corp.CNVS

$0-100%

Other financials

Income statement

See full

Revenue-—

Net income-$7.5M-13.1%

EPS (diluted)-$0.13+13.3%

Balance sheet

See full

Cash & equivalents$6.3M+1.3%

Total debt$456.9K+178%

Total equity$23.2M+135%

Total assets$29.7M+103%

Cash flow

See full

Operating cash flow-$4.4M+6.9%

CapEx$48.8K+14.5%

Free cash flow-$4.5M+6.7%

Valuation

See full

Market cap$155.39M+45.8%

Enterprise value$149.54M+52.3%

Returns & leverage

See full

Return on equity-187.2%—

Debt / equity0×0.0×

Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfAssumedDebt.

The official record: TuHURA Biosciences, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s repayments of assumed debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s repayments of assumed debt?: TuHURA Biosciences, Inc. (HURA) reported repayments of assumed debt of $108.5K in Q4 2025.
What does repayments of assumed debt mean?: This measures the cash outflows used to satisfy debt obligations that were inherited through a business acquisition or merger. It reflects the company's commitment to deleveraging and managing the capital structure post-transaction.